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five-year follow up in MS patients and their association with clini-
cal and cognitive deterioration.
Methods: Clinical (EDSS and phenotype changes), neuropsycho-
logical (Rao’s battery) and brain MRI (dual-echo and 3D 
T1-weighted sequences) assessment were performed at baseline 
(T0) and after 5 years (Y5) from 66 MS patients with the main 
disease clinical phenotypes and 10 controls. At T0 and Y5, meas-
ures of brain lesion volume and regional brain atrophy were 
obtained. Tensor-Based Morphometry (TBM) and SPM12 was 
used to assess longitudinal changes of GM and WM volumes in 
MS patients after 5 years and according to the presence of neuro-
logic deterioration, phenotype modification and cognitive 
worsening.
Results: At Y5, 36/66 (55%) MS patients showed a significant 
disability worsening, 14/66 (21%) evolved to a worse clinical 
phenotype and 18/63 (29%) had a worsening of cognitive func-
tions. At baseline, compared to controls, MS patients showed a 
widespread pattern of GM and WM atrophy. At Y5, MS patients 
developed further GM atrophy of several deep GM nuclei includ-
ing the thalami, putamen and caudate nuclei, as well as of several 
fronto-temporo-parieto-occipital regions and the cerebellum. 
Progression of atrophy of the main WM tracts was also detected. 
Compared to stable MS patients, those with clinical and cognitive 
worsening showed a left-lateralized pattern of GM and WM atro-
phy, involving the thalamus, caudate nucleus and putamen, sev-
eral fronto-temporo-parieto-occipital regions, the cerebellum and 
the majority of WM tracts.
Conclusions: GM and WM atrophy of relevant brain regions 
occurs in MS after 5 years. A different vulnerability of the two 
brain hemispheres to irreversible structural damage may be among 
the factors contributing to clinical and cognitive worsening in 
these patients.
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Background: The identification and segmentation of focal hyper-
intense lesions on Magnetic Resonance Images (MRI) are essen-
tial steps in multiple sclerosis (MS) patients. Despite many 
automatic methods for MS lesion segmentation have been pro-
posed in the last 15 years, manual segmentation is still considered 
the gold standard. This is due to the fact that not all lesions are 
correctly identified employing automated techniques.
Objectives: Aim of this study was to develop a method for MS 
lesion segmentation based on Dual-Echo MRI sequence and a 
priori information. This ensures an improved classification of 
lesions and a considerable gain in time required for the 
segmentation.
Methods: Brain dual-echo MRI acquired on a 3.0 T Philips 
Achieva scanner was obtained in 10 MS patients used for the 
training set and 20 MS patients used for the validation (lesion load 
0.3÷9 ml). Lesions were identified by an expert neurologist on the 
Proton Density-weighted (PD-w) images with marker points, and 
these were used to expand the segmentation of lesions constrained 
by intensity similarity and edge detection. An intensity threshold 
was defined for each marker using a curve extracted after a train-
ing process on manual segmented lesions. A new half-way con-
trast image was obtained averaging the PD-w and the T2-W 
image, to take advantage of both images tissue contrasts, and this 
was high-pass filtered to enhance lesion edges. Finally a more 
robust threshold was estimated using lesion values distribution to 
refine the segmentation according to these new threshold values. 
The segmentation obtained was compared to the manual one.
Results: These results are the mean metrics evaluated for all 
patients: Dice Similarity Coefficient (DSC) = 0.8, Mean Square 
Error (MSE) = 0.2 ml, True Positive Fraction (TPF) = 0.9, False 
Positive Fraction (FPF) = 0.1 and False Negative Fraction 
(FNF) = 0.2.
Conclusions: Lesion segmentation performed with this method 
revealed high similarity with the ground truth. FPF and FNF indi-
cated low misclassification of lesions. Moreover process time was 
drastically reduced of about 96 minutes for the maximum lesion 
load considered.
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We describe the untrained MS lesion segmentation method 
MSmetrix and its results on the longitudinal MS lesion segmenta-
tion challenge organised at the ISBI 2015 conference. The organ-
isers provided 5 training and 15 test datasets, consisting of 
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T1-weighted, T2-weighted, FLAIR and PD-weighted MRIs of 
MS patients scanned 3-5 times with an interval of approximately 
one year on a 3T MR scanner. Competing methods were evaluated 
independently by the organisers based on expert segmentations 
with respect to accuracy and ability to track lesion evolution.
MSmetrix takes as input 3D T1-weighted and 3D FLAIR brain 
images acquired from an MS patient. The images are preproc-
essed and co-registered before executing the main loop of the 
algorithm consisting of three iterated steps: brain segmentation, 
lesion segmentation, and lesion filling. The T1-weighted image is 
segmented into grey matter (GM), white matter (WM) and cere-
brospinal fluid (CSF) using a probabilistic model and the expecta-
tion-maximisation algorithm. Lesion segmentation is then 
performed using the FLAIR image with GM, WM and CSF seg-
mentations as priors. The lesion segmentation is used to fill in the 
lesions in the T1-weighted image with WM intensities. These 
three steps are repeated until there is no significant change in the 
lesion segmentation. Unlike training based methods, MSmetrix 
makes no prior assumptions on the lesion size or shape and is 
scanner independent.
We applied MSmetrix on the test datasets of the ISBI challenge 
without prior tuning on the training datasets. MSmetrix´s normal-
ised Dice score relative to inter-rater metrics was 0.94, which was 
the same as the winning (trained) method. The average linear cor-
relation of changes in lesion volumes between successive time 
points for MSmetrix was 0.33, which was the highest correlation 
after the winning method (0.55). These results illustrate that 
MSmetrix is an accurate untrained method for longitudinal MS 
lesion segmentation, requiring only 3D T1 and 3D FLAIR and 
outperforming other state-of-the-art untrained methods.
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Background: Brain volume and brain volume loss measures are 
newly recognized biomarkers of neurodegeneration in multiple 
sclerosis (MS). Statistical Parametric Mapping (SPM), SIENA 
and its cross-sectional version SIENAX are well established tools 
to quantify brain volume as well as brain volume changes.
Objectives: To compare intra- and inter-scanner variability of 
SPM12, SIENA, and SIENAX. For each tissue compartment and 
each method the impact of measurement variability on longitudi-
nal volumetric studies was assessed. Minimum percentage vol-
ume differences necessary to detect a significant volume change 
between two measurements in the same subject were determined.
Methods: Three-dimensional (3D) T1-weighted magnetization 
prepared rapid gradient echo (MPRAGE) scans of 51 healthy sub-
jects were included into this study. Each subject was scanned 
twice on two different scanner platforms at 1.5 T and 3 T field 
strengths (total=4 scans) within a period of a few weeks. In total, 
204 images were downloaded from the Alzheimer´s Disease 
Neuroimaging Initiative (ADNI) repository. The data was 
acquired at 50 different imaging centers. The two scans were 
acquired back-to-back during a single imaging session. Since no 
atrophy is expected the percentage volume change between the 
two scans can be used as a measure of error. For each patient intra-
scanner (1.5 T vs. 1.5 T and 3 T vs. 3 T scan) and inter-scanner 
errors (first 1.5 T vs. first 3 T scan) were determined.
Results: The 5%-, 50%- and 95%-percentiles of the absolute 
errors for total brain volume in the intra-scanner setting were 
[0.05, 0.24, 1.28] for SPM12, [0.16, 1.93, 14.38] for SIENAX, 
and [0.01,0.15, 0.9] for SIENA. The minimum percentage volume 
difference necessary to detect a significant (p=0.05) volume 
change between two measurements in the same subject is there-
fore 1.28% for SPM12, 14.38% for SIENAX, and 0.9% for 
SIENA. The 5%, 50% and 95% percentiles of the absolute errors 
for total brain volume in the inter-scanner setting were [0.21, 1.74, 
5.44] for SPM12, [0.61, 4.96, 19.67] for SIENAX, and 
[0.20,1.57,4.97] for SIENA.
Conclusions: SIENA appears better suited than SPM12 for longi-
tudinal measurements in the intra-scanner setting. SPM12 has a 
much lower variability than SIENAX and hence might be better 
suited for cross-sectional measurements. All methods feature a 
significantly higher variability when baseline and follow-up scans 
were acquired on different devices with different field strengths.
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Background: Cognitive dysfunction in multiple sclerosis (MS) is 
highly prevalent, but still poorly understood. Previously we have 
shown a cognitively relevant network imbalance in MS using 
eigenvector centrality mapping (ECM). In this study, we expanded 
on these results by dividing the group into different severities of 
cognitive impairment.
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